FDA Seeks To Speed Seizure, Injunction Decisions Via More Collaborative Intra-Agency Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Associate Commissioner for Regulatory Affairs Dara Corrigan tells FDLI that sequential review by multiple FDA offices slows down enforcement actions.
You may also be interested in...
FDA's New ORA Head, Dara Corrigan, Has Broad Enforcement Experience
Former acting HHS inspector general will become associate commissioner for regulatory affairs two years after Margaret O'Keeffe Glavin's retirement.
Hamburg Offers "Close Out" Carrot To Firms In Plan To Accelerate Enforcement
FDA enforcement initiative eliminates requirement for all warning letters to be reviewed by Office of Chief Counsel.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.